Characterization of selenium and glutathione status in critically ill children.

Not Applicable

Completed

• Conditions: Critically ill; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12616001119482
• Lead Sponsor: Karolinska University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-08-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

<18 years of age; BW >1000 grams; expected time in PICU >24 hours

Exclusion Criteria

BW <1000 grams; Age >= 18 years; Expected time in PICU <24 hours; moribund patient

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Characterize serum Selenium concentration at admission to Intensive care and at day five.[Day 5 compared to Admission (Day 1).];Investigate if Serum Glutathione status at Admission and day five is linked to serum Selenium concentration.[Day 5 compared to admission (Day 1).]

Secondary Outcome Measures

Name	Time	Method
Organ failure assessment according to PELOD Score at Admission and day five, and correlation to serum Selenium concentration.[Day 5 compared to admission (Day 1).]